Skip to main content
Explore URMC
menu

Scott A. Gerber, Ph.D.

Contact Information

Phone Numbers

Administrative: (585) 275-1488

Office: (585) 276-7380

Research Labs

Faculty Appointments

Biography

Research

Dr. Gerber is a tumor immunologist whose laboratory focuses on harnessing the immune system to recognize and kill cancerous cells. His lab uses an immunotherapeutic approach to enhance the efficacy of chemo/radiotherapies to control or even cure both primary and metastatic malignancies.

Credentials

Education

1997
BS | SUNY Coll at Fredonia
Biology

2001
MS | University of Rochester School of Medicine & Dentistry
Immunology

2005
PhD | University of Rochester School of Medicine & Dentistry
Microbiology & Immunology

Post-doctoral Training & Residency

2005 - 2008
Yale University, New Haven, CT (Mentor: Jordan Pober)

Awards

2019
National Cancer Institute R01 CA230277

2019
URMC Outstanding Graduate Student Teacher Award

2018 - 2019
University Research Award

2018
Clinical and Translational Science Institute Pilot Study Award

2017
Wilmot Cancer Institute Collaborative Award

2016
Washington University SPORE in Pancreatic Cancer Developmental Research Award

2016
UR/UB Genomics Collaborative Pilot Award

2012 - 2013
American Association of Immunologist (AAI) Early Career Faculty Travel Grant

2008
Anna Fuller Fund Fellowship in Molecular Oncology
Sponsor: Yale University
Location: New Haven, CT

2006
Vincent du Vigneaud Award for outstanding doctoral thesis
Sponsor: University of Rochester Medical Center
Location: Rochester, NY

VIEW ALL expand_more

Publications

Journal Articles

5/11/2021
Qin SS, Han BJ, Williams A, Jackson KM, Jewell R, Chacon AC, Lord EM, Linehan DC, Kim M, Reuben A, Gerber SA, Prieto PA. "Intertumoral Genetic Heterogeneity Generates Distinct Tumor Microenvironments in a Novel Murine Synchronous Melanoma Model." Cancers.. 2021 May 11; 13(10)Epub 2021 May 11.

5/7/2021
Cole CL, Bachman JF, Ye J, Murphy J, Gerber SA, Beck CA, Boyce BF, Muthukrishnan G, Chakkalakal JV, Schwarz EM, Linehan D. "Increased myocellular lipid and IGFBP-3 expression in a pre-clinical model of pancreatic cancer-related skeletal muscle wasting." Journal of cachexia, sarcopenia and muscle.. 2021 May 7; Epub 2021 May 07.

4/29/2021
Battaglia NG, Uccello TP, Hughson A, Garrett-Larsen J, Caldon JJ, Qiu H, Gerber SA, Lord EM. "Co-administration of a clinically relevant dexamethasone dosage with ablative radiotherapy reduces peripheral lymphocytes but does not alter in vivo intratumoral lymphocyte phenotype or inhibit efficacy of radiotherapy in a murine colorectal tumor model." International journal of radiation oncology, biology, physics.. 2021 Apr 29; Epub 2021 Apr 29.

VIEW ALL PUBLICATIONS